GFC Life Science Co., Ltd (388610.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩4,545 (-2.68%) as of
Key statistics
- Market cap
- 24.15B
- Dividend yield
- 0.00%
- 52-week range
- 4,315.00 – 18,570.00
- Beta
- 0.70
- Revenue (TTM)
- 19.24B
- Profit margin
- 5.59%
- Volume
- 9.45k
About GFC Life Science Co., Ltd
GFC Life Science Co., Ltd develops cosmetic, food, and medical materials. The company develops bio-materials in the areas of human bio-technology, bio-phytochemistry, bio-fermentation, unique bio-technology, and biocompatible formula technology. It also offers scientific and systematic research services on human application testing. The company was formerly known as GFC Co., Ltd and changed its name to GFC Life Science Co., Ltd in 2018. GFC Life Science Co., Ltd was founded in 2002 and is headquartered in Hwaseong-si, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Hwaseong-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.